Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
Ovarian cancer is the fifth leading cause of cancer death for women in the U.S. and the seventh most fatal worldwide. Although ovarian cancer is notable for its initial sensitivity to platinum-based therapies, the vast majority of patients eventually develop recurrent cancer and succumb to increasin...
Main Authors: | Bentink, Stefan, Haibe-Kains, Benjamin, Risch, Thomas, Fan, Jian-Bing, Hirsch, Michelle S., Holton, Kristina, Rubio, Renee, April, Craig, Chen, Jing, Wickham-Garcia, Eliza, Liu, Joyce, Culhane, Aedin, Drapkin, Ronny, Quackenbush, John, Matulonis, Ursula A. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278409/ |
Similar Items
-
Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis
by: Schwede, Matthew, et al.
Published: (2013) -
High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the Ovary
by: Matulonis, Ursula A., et al.
Published: (2011) -
Using shRNA experiments to validate gene regulatory networks
by: Olsen, Catharina, et al.
Published: (2015) -
iBBiG: iterative binary bi-clustering of gene sets
by: Gusenleitner, Daniel, et al.
Published: (2012) -
Significance Analysis of Prognostic Signatures
by: Beck, Andrew H., et al.
Published: (2013)